CY1120282T1 - Φαρμακευτικη συνθεση κιτρικης σιλδεναφιλης με την μορφη ενος εναιωρηματος για εκ του στοματος χρηση - Google Patents
Φαρμακευτικη συνθεση κιτρικης σιλδεναφιλης με την μορφη ενος εναιωρηματος για εκ του στοματος χρησηInfo
- Publication number
- CY1120282T1 CY1120282T1 CY20181100569T CY181100569T CY1120282T1 CY 1120282 T1 CY1120282 T1 CY 1120282T1 CY 20181100569 T CY20181100569 T CY 20181100569T CY 181100569 T CY181100569 T CY 181100569T CY 1120282 T1 CY1120282 T1 CY 1120282T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- suspension
- sildenafil
- citrus
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μια φαρμακευτική σύνθεση κιτρικής σιλδεναφίλης με τη μορφή ενός εναιωρήματος για χορήγηση εκ του στόματος που περιλαμβάνει ύδωρ ως μια ουσία-όχημα και κόμμι ξανθάνης και υπρομελλόζη ως παράγοντες εναιώρησης, που είναι κατ' εξοχήν σταθερό και επιτρέπει την αποτελεσματική απόκρυψη της πικρής γεύσης του ενεργού συστατικού μείγματος. Αναφέρεται επίσης σε μια διαδικασία για την παρασκευή του εν λόγω εναιωρήματος και σε έναν περιέκτη που περιέχει αυτή και που παρέχεται με μια τεχνολογική συσκευή δοσολόγησης για τη χορήγηση αυτής. Αυτή η σύνθεση κιτρικής σιλδεναφίλης στη μορφή ενός εναιωρήματος είναι κατάλληλη για χορήγηση εκ του στόματος για την αγωγή της σεξουαλικής δυσλειτουργίας των αρρένων.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201500212A ES2584248B1 (es) | 2015-03-24 | 2015-03-24 | Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1120282T1 true CY1120282T1 (el) | 2019-07-10 |
Family
ID=55646513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20181100569T CY1120282T1 (el) | 2015-03-24 | 2018-05-25 | Φαρμακευτικη συνθεση κιτρικης σιλδεναφιλης με την μορφη ενος εναιωρηματος για εκ του στοματος χρηση |
Country Status (11)
Country | Link |
---|---|
US (1) | US10016428B2 (el) |
EP (1) | EP3072515B1 (el) |
AU (1) | AU2017265087B2 (el) |
CY (1) | CY1120282T1 (el) |
DK (1) | DK3072515T3 (el) |
ES (2) | ES2584248B1 (el) |
HR (1) | HRP20180819T1 (el) |
HU (1) | HUE037541T2 (el) |
MX (1) | MX369760B (el) |
PL (1) | PL3072515T3 (el) |
PT (1) | PT3072515T (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3731870A1 (en) * | 2017-12-26 | 2020-11-04 | FTF Pharma Private Limited | Liquid oral formulations for pde v inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
US20070087981A1 (en) * | 2002-02-08 | 2007-04-19 | Lavipharm Laboratories, Inc. | Water Soluble and Palatable Complexes |
US20060024335A1 (en) * | 2004-07-29 | 2006-02-02 | Roger Stier E | Oral compositions which mask the bitter taste of a bitter-tasting agent |
US20090047330A1 (en) * | 2007-08-17 | 2009-02-19 | Ramesh Bangalore | Oral fast dissolving films for erectile dysfunction bioactive agents |
EP2222273A2 (en) * | 2007-11-12 | 2010-09-01 | Novartis AG | Liquid compositions comprising valsartan |
CN105250242B (zh) * | 2011-02-11 | 2018-09-21 | 西梯茜生命工学股份有限公司 | 包含西地那非游离碱的膜制剂及其生产方法 |
ES2475942B1 (es) * | 2013-01-11 | 2015-04-16 | Farmalider, S.A. | Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa |
MX2013001279A (es) * | 2013-01-31 | 2013-08-26 | Miguel Angel Garcia Perez | Composicion farmaceutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral. |
-
2015
- 2015-03-24 ES ES201500212A patent/ES2584248B1/es not_active Expired - Fee Related
-
2016
- 2016-03-14 MX MX2016003327A patent/MX369760B/es active IP Right Grant
- 2016-03-15 PL PL16380008T patent/PL3072515T3/pl unknown
- 2016-03-15 EP EP16380008.9A patent/EP3072515B1/en active Active
- 2016-03-15 PT PT163800089T patent/PT3072515T/pt unknown
- 2016-03-15 ES ES16380008.9T patent/ES2671543T3/es active Active
- 2016-03-15 DK DK16380008.9T patent/DK3072515T3/da active
- 2016-03-15 HU HUE16380008A patent/HUE037541T2/hu unknown
- 2016-03-22 US US15/076,858 patent/US10016428B2/en active Active
-
2017
- 2017-11-23 AU AU2017265087A patent/AU2017265087B2/en active Active
-
2018
- 2018-05-24 HR HRP20180819TT patent/HRP20180819T1/hr unknown
- 2018-05-25 CY CY20181100569T patent/CY1120282T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2671543T3 (es) | 2018-06-07 |
EP3072515B1 (en) | 2018-02-28 |
ES2584248A1 (es) | 2016-09-26 |
HRP20180819T1 (hr) | 2018-07-13 |
EP3072515A1 (en) | 2016-09-28 |
AU2017265087A1 (en) | 2018-01-04 |
AU2017265087B2 (en) | 2018-11-01 |
HUE037541T2 (hu) | 2018-09-28 |
US10016428B2 (en) | 2018-07-10 |
ES2584248B1 (es) | 2017-04-19 |
MX2016003327A (es) | 2017-01-05 |
MX369760B (es) | 2019-11-20 |
DK3072515T3 (en) | 2020-01-06 |
US20160279133A1 (en) | 2016-09-29 |
PL3072515T3 (pl) | 2018-12-31 |
PT3072515T (pt) | 2018-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122566T1 (el) | Παραγωγο 6,7,8,9-tetpaϋδpo-3h-πυραζολo[4,3-f] ισοκινολινης χρησιμο στη θεραπευτικη αντιμετωπιση του καρκινου | |
CY1121698T1 (el) | Υγρο σκευασμα για εισπνοη που περιεχει rpl554 | |
CY1122792T1 (el) | Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου δαγκειου ιου | |
CY1124052T1 (el) | Δισκιο διασπειρομενο στο στομα περιεχον οιστετρολη | |
EA201992162A1 (ru) | Составы на основе нирапариба | |
EA201691454A1 (ru) | Композиции придопидина модифицированного высвобождения | |
MX2016010179A (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
EA201792592A1 (ru) | Фармацевтические препараты, содержащие тенофовир и эмтрицитабин | |
CY1123366T1 (el) | Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου | |
ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
CY1122899T1 (el) | Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη | |
CY1122882T1 (el) | Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
CY1124893T1 (el) | Φαρμακευτικο μeιγμα μαροπιταντης | |
CY1121921T1 (el) | Φαρμακευτικα σκευασματα | |
EA201792144A1 (ru) | Стабильный препарат для парентерального введения тапентадола | |
CY1120282T1 (el) | Φαρμακευτικη συνθεση κιτρικης σιλδεναφιλης με την μορφη ενος εναιωρηματος για εκ του στοματος χρηση | |
EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
MX2019005160A (es) | Formulacion farmaceutica. | |
MX2017015202A (es) | Formulaciones liquidas de celecoxib para administracion oral. | |
EA201991817A1 (ru) | Интраназальная композиция, включающая бетагистин | |
EA201891860A1 (ru) | Фармацевтическая композиция пролонгированного высвобождения, содержащая цистеамин или его соли | |
EA202091127A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
RU2014107146A (ru) | Способ профилактики канцерогенного действия диэтилнитрозамина у экспериментальных животных | |
CY1120749T1 (el) | Φαρμακευτικες δοσολογικες μορφες |